Jefferies upgraded Cardinal Health (NYSE:CAH) to buy from hold, citing management's "impressive" EPS track record. The investment bank said that after ten quarters it believes the company's earnings ...
Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong ...
Hosted on MSN1d
Jefferies Upgrades Cardinal Health (CAH)Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.
Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...
Stocks to Buy or Sell. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against ...
Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...
Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating ...
Dublin City Schools has officially backed out of a deal to acquire the vacant Cardinal Health office building, pivoting ...
Latest data shows the largest indicative borrow rate increases among liquid option names include: Sellas Life Sciences (SLS) 69.57% +2.56, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback